Technology News and Research

RSS

Errors in Deloitte-run Medicaid systems can cost millions and take years to fix

The computer systems run by the consulting giant Deloitte that millions of Americans rely on for Medicaid and other government benefits are prone to errors that can take years and hundreds of millions of dollars to update.

5 Sep 2024

ERS Genomics and medicines discovery catapult sign CRISPR/Cas9 license agreement

Dublin, Ireland, and Cheshire, UK, 04 September 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug discovery innovation center, have signed a non-exclusive commercial-use CRISPR license agreement.

From ERS Genomics 5 Sep 2024

Scientists advance type 1 diabetes treatment with cutting-edge stem cell and gene editing technologies

Researchers review significant advancements and ongoing challenges in cell replacement therapies for type 1 diabetes, highlighting innovative approaches in stem cell-derived islets and immune protection strategies.

5 Sep 2024

High-precision X-rays uncover the mechanics of neck pain

Learning new languages, sending emails, attending a virtual class, or speaking to loved ones halfway around the world are just some of the tasks accomplished by touching a button on a smartphone. Unfortunately, the ease and convenience of modern devices have also come with a painful crick in the neck. The sedentary nature of work and prolonged use of hand-held devices and computers have contributed to a sharp increase in neck pain.

5 Sep 2024

Genetic testing: A game-changer for healthcare

As genetic sequencing technology becomes more accessible and efficient, researchers have made significant strides in understanding the genetic underpinnings of various diseases. This knowledge has led to a surge in clinical applications of genetic testing, offering hope and improved outcomes for individuals affected by many genetic diseases and disorders.

5 Sep 2024

Promising new strategy to combat fungal infections

A group of Brazilian researchers has found a potential target for novel therapeutic strategies to combat fungal infections – more specifically, those caused by Aspergillus fumigatus. An article reporting the discovery is published in the journal Communications Biology.

5 Sep 2024

Allen Institute and NYSCF launch collaboration to create inclusive cellular models

Today, the Allen Institute for Cell Science and New York Stem Cell Foundation (NYSCF) announced a pioneering collaboration to address this critical issue, combining two cutting-edge technologies to create more inclusive cellular models for studying disease.

4 Sep 2024

Study reassures patients about semaglutide safety

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.

4 Sep 2024

NIH funds study on complex evolutionary adaptation in human DNA

Natural selection is an important evolutionary force that enables humans to adapt to new environments and fight disease-causing pathogens.

3 Sep 2024

Newly discovered antibody can neutralize all known variants of SARS-CoV-2

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.

3 Sep 2024

NIAID awards grants for 10 projects to improve diagnostic tools for syphilis

The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) has awarded grants for 10 projects to improve diagnostic tools for congenital and adult syphilis - conditions currently diagnosed with a sequence of tests, each with limited precision.

3 Sep 2024

RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research

The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the use of RNA technologies within and beyond the Mass General Brigham research ecosystem.

3 Sep 2024

NSF AIRFoundry to advance RNA technology and nanoparticle design

In a typical foundry, raw materials like steel and copper are melted down and poured into molds to assume new shapes and functions.

3 Sep 2024

New framework advocates for post-digital sexual citizenship to combat school violence

Sexual and gender-based violence (SGBV) in schools across England is not merely a series of isolated incidents but a deeply rooted systemic issue.

3 Sep 2024

Sapio Sciences advances the world's first AI-powered lab assistant

Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations.

From Sapio Sciences 3 Sep 2024

Aptamer extends contract with Unilever to progress Optimer for deodorant development

Lab-test results of Optimer indicate good applicability in deodorant products.

From Aptamer Group 3 Sep 2024

Researchers develop stable compound for targeted alpha therapy in prostate cancer

Compounds containing astatine-211 (211At) can be used in targeted radiotherapies for prostate cancer, but deastatination in the body remains a significant hurdle.

3 Sep 2024

European Society of Cardiology highlights underrecognized link between obesity and heart disease

Obesity is a key factor in cardiovascular disease, prompting the ESC to recommend comprehensive strategies for prevention and management to reduce health risks.

3 Sep 2024

New research initiative aims to position Australia at the forefront of quantum biotechnology

The University of Queensland has launched a $45 million research initiative to position Australia as a global leader in quantum biotechnology, and tackle some of the world's biggest challenges.

2 Sep 2024

UNICEF issues emergency tender for mpox vaccine procurement

UNICEF today announced that it has issued an emergency tender for the procurement of mpox vaccines. Vaccines can play a critical role in containing the mpox outbreak which was declared a public health emergency by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO).

2 Sep 2024

Technology News and Research

Errors in Deloitte-run Medicaid systems can cost millions and take years to fix

ERS Genomics and medicines discovery catapult sign CRISPR/Cas9 license agreement

Scientists advance type 1 diabetes treatment with cutting-edge stem cell and gene editing technologies

High-precision X-rays uncover the mechanics of neck pain

Genetic testing: A game-changer for healthcare

Promising new strategy to combat fungal infections

Allen Institute and NYSCF launch collaboration to create inclusive cellular models

Study reassures patients about semaglutide safety

NIH funds study on complex evolutionary adaptation in human DNA

Newly discovered antibody can neutralize all known variants of SARS-CoV-2

NIAID awards grants for 10 projects to improve diagnostic tools for syphilis

RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research

NSF AIRFoundry to advance RNA technology and nanoparticle design

New framework advocates for post-digital sexual citizenship to combat school violence

Sapio Sciences advances the world's first AI-powered lab assistant

Aptamer extends contract with Unilever to progress Optimer for deodorant development

Researchers develop stable compound for targeted alpha therapy in prostate cancer

European Society of Cardiology highlights underrecognized link between obesity and heart disease

New research initiative aims to position Australia at the forefront of quantum biotechnology

UNICEF issues emergency tender for mpox vaccine procurement

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News